Implications of Biological and Procedural Factors of 18-f FDG PET/CT Uptake by Normal Organs and Neoplastic Lesions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Oncologic Diseases
- Sponsor
- mahenoor alaa eldeen naem
- Enrollment
- 259
- Locations
- 1
- Primary Endpoint
- PET/CT scan on cancer patient will be performed to evaluate the biological and procedural factors of 18-f FDG uptake by multiple normal organs and neoplastic lesions using Standardized uptake values
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
To evaluate implications of biological and procedural factors of 18-f FDG PET/CT uptake on normal organs and neoplastic lesions.
Detailed Description
18-f FDG is used on oncological patients undergoing PET/CT study at our nuclear medicine unit , its uptake by the tissues depends on glucose blood level and consumption then we evaluate the implications of biological and procedural factors on the uptake by normal organs and neoplastic lesions using standardized uptake values SUVmax , mean and peak.
Investigators
mahenoor alaa eldeen naem
Doctor
Assiut University
Eligibility Criteria
Inclusion Criteria
- •cancer patients referred to nuclear medicine unit
Exclusion Criteria
- •patients with increased FDG uptake associated with non malignant causes such as diffuse bone marrow FDG uptake or lung infection or patients with extensive metastasis in target organs
Outcomes
Primary Outcomes
PET/CT scan on cancer patient will be performed to evaluate the biological and procedural factors of 18-f FDG uptake by multiple normal organs and neoplastic lesions using Standardized uptake values
Time Frame: 2 years
SUV mean , suv peak and suv max